๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers Clinical trials Hyderabad
Clinical trial register · India

Clinical Trials in Hyderabad

Every study on the ClinicalTrials.gov registry that lists a site in India and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 1123 matching records held by the registry are in this view. Synced 20 Sep 2026, 03:16 UTC
1123
Studies in scope
all four open statuses
610
Recruiting now
open to new participants
222
Lead sponsors
across recruiting studies
Top sites
New Delhi 332 Mumbai 259 Hyderabad 237 Bangalore 193 Pune 189
Narrow the registerReset
Recruitment status
Phase
Site location
New Delhi332 Mumbai259 Hyderabad237 Bangalore193 Pune189
All 274 locations
Target enrolment
to
237 of 1123 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Indian sites
Start
Recruiting
A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib
NCT07623161Myelofibrosis, Anemia
Takeda
Phase 3
324
Gurgaon, Kochi, Thiruvananthapuram, Pune, New Delhi, Rohini, Chennai, Hyderabad
2026-09-02
Recruiting
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
NCT07761117Heart Failure With Preserved Ejection Fraction (HFpEF), Heart Failure With Mildly Reduced Ejection Fraction (HFmrEF)
AstraZeneca
Phase 3
6,950
Belagavi, Calicut, Coimbatore, Dehradun, Delhi, Hyderabad, Jaipur, Kanpur
2026-08-24
Not yet open
EUS-Guided ATI and SWE in Individuals With Normal FibroScan
NCT07714941Non-hepatobiliary Indications
Asian Institute of Gastroenterology, India
Observational
100
Hyderabad
2026-08-20
Recruiting
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
NCT07784725Obesity or Overweight
AstraZeneca
Phase 3
2,500
Bhubaneswar, Coimbatore, Hyderabad, Indore, Jaipur, Jodhpur, Kochi, Kolkata
2026-08-19
Recruiting
A Multicentre Observational Cross-Sectional Study of The Gastric Precancerous Epithelial Pathway Using High-Definition Endoscopy And Histopathology In India
NCT07486518Gastric Adenocarcinoma, Early Gastric Cancer
Asian Institute of Gastroenterology, India
Observational
4,000
Hyderabad
2026-08-01
Recruiting
A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis
NCT07497087Systemic Sclerosis
Boehringer Ingelheim
Phase 3
448
Bangalore, Bhubaneswar, Gurugram, Hyderabad, Kochi, Maharashtra, New Delhi
2026-07-27
Recruiting
Safety and Efficacy of Underwater Endoscopic Mucosal Resection for Type I Gastric Neuroendocrine Tumors Measuring 5-9 mm
NCT07728292Stomach Neuroendocrine Neoplasm
Asian Institute of Gastroenterology, India
Not applicable
60
Hyderabad
2026-07-17
Recruiting
A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes Who Observe Ramadan Fasting
NCT07613307Diabetes Mellitus, Type 2, Diabetes Melletus, Glucose Metabolism Disorders, Metabolic Disorders
Eli Lilly and Company
Phase 3
130
Agra, Hyderabad, Kanpur, Kolkata, Mumbai, Mysore, Nashik, Nellore
2026-07-15
Recruiting
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background Insulin
NCT07664553Type 2 Diabetes Mellitus
AstraZeneca
Phase 3
600
Bangalore, Belagavi, Chennai, Coimbatore, Guntur, Hyderabad, Indore, Kochi
2026-07-08
Recruiting
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
NCT07667803Weight Management
AstraZeneca
Phase 3
4,500
Bangalore, Belagavi, Bikaner, Delhi, Guntur, Hyderabad, Jaipur, Jodhpur
2026-06-29
Recruiting
Dimotec (Diosmin) 1000 mg Film Coated Tablet Fed Study
NCT07674446Healthy Volunteers
Keri Pharma Hungary Kft
Phase 1
72
Hyderabad
2026-06-29
Recruiting
Simple Non-cultured Endothelial Cell Therapy for Corneal Endothelial Dysfunction
NCT07711561Bullous Keratopathy, Corneal Endothelial Dystrophy
Singapore Eye Research Institute
Phase 1
20
Hyderabad
2026-06-22
Not yet open
RESTOREGI Study: Regenerative Endoscopic Stromal Therapy: Outcomes and Risk Factor Evaluation in GI Fistulas
NCT07661043Fistula, Regenerative Medicine, Stromal Vascular Fraction
Asian Institute of Gastroenterology, India
Not applicable
50
Hyderabad
2026-06-15
Not yet open
To Assess Dose Proportionality and Pharmacokinetic Linearity of Saninova Tablets in Healthy Participants Under Fasting Conditions
NCT07664657Bioavailability and Pharmacokinetics
Sichuan Credit Pharmaceutical Co., Ltd.
Not applicable
32
Hyderabad
2026-06
Recruiting
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
NCT07577856Colitis, Ulcerative
Janssen Research & Development, LLC
Phase 3
644
Hubballi, Hyderabad, Jaipur, Kochi, Secunderabad, Surat
2026-05-23
Recruiting
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
NCT07577843Crohn Disease
Janssen Research & Development, LLC
Phase 3
460
Hubballi, Hyderabad, Jaipur, Kochi, Secunderabad, Surat
2026-05-22
Recruiting
A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
NCT07422480Myelodysplastic Syndrome, Anemia
Takeda
Phase 3
300
Kochi, Pune, Vellore, Hyderabad, Chandigarh, Delhi
2026-05-21
Recruiting
Conduction System Pacing Display Research System for SmartSync Pacing System Analyzer
NCT07733960Bradycardia
Medtronic Cardiac Rhythm and Heart Failure
Observational
100
Madurai, Hyderabad
2026-05-21
Active, closed
Biological Optimization Versus Standard Care in Post-POEM Achalasia Patients (BIO-POEM)
NCT07620899Achalasia Cardia, GERD (Gastroesophageal Reflux Disease)
Asian Institute of Gastroenterology, India
Not applicable
166
Hyderabad
2026-05-20
Recruiting
Composite Index for Outcome Burden in Acute Cholangitis
NCT07667166Acute Cholangitis, Biliary Drainage
Asian Institute of Gastroenterology, India
Observational
514
Hyderabad
2026-04-20
Recruiting
Regenerative Endoscopy in Refractory Perianal Crohn's Disease
NCT07652632Crohn Disease (CD), Perianal Crohns Disease
Asian Institute of Gastroenterology, India
Not applicable
50
Hyderabad
2026-04-20
Recruiting
Pancreatic Enzyme Replacement in Acute Necrotizing Pancreatitis
NCT07441824Acute Necrotizing Pancreatitis, Pancreatic Exocrine Insufficiency
Asian Institute of Gastroenterology, India
Phase 3
140
Guwahati, Hyderabad, Kolkata
2026-04-10
Recruiting
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
NCT07415044Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate, Ulcerative Colitis, Active Severe
Eli Lilly and Company
Phase 2
1,431
Allahฤbฤd, Belagavi, Belgavi, Hyderabad, Jaipur, Kochi, Lucknow, Mumbai
2026-03-26
Recruiting
A Study to Compare the Effectiveness and Safety of T1695 Versus Ciclosporin in Participants With Moderate to Severe Vernal Keratoconjunctivitis
NCT07169695Moderate to Severe Vernal Keratoconjunctivitis
Laboratoires Thea
Phase 2
120
Kolkata, Ahmedabad, Bangalore, Hyderabad, Jaipur, Patna, Pune, Surat
2026-03-24
Recruiting
PODOMOUNT-Basket, a Study to Test Whether BI 764198 Helps Adults and Adolescents With Different Types of Kidney Disease
NCT07355296Proteinuric Kidney Diseases
Boehringer Ingelheim
Phase 2
132
Ahmedabad, Bhubaneswar, Hyderabad, Kozhikode, Lucknow, Mysore, Pune, Varanasi
2026-03-23
Rows per page Showing 1–25 of 237
1 2 3 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Indian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 21 September 2026. https://priyalifescience.com/clinical-trials-india/city/hyderabad

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.